ALX ONCOLOGY HOLDINGS INC 10-Q filing
Filed 2026-05-08 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-213399
- Form type
- 10-Q
- CIK
- 0001810182
- Primary document
- https://www.sec.gov/Archives/edgar/data/1810182/000119312526213399/alxo-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ALX ONCOLOGY HOLDINGS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-19.0M | - | - |
| Net Income | $-17.9M | - | - |
| Eps Basic | -0.17 | - | - |
| Eps Diluted | -0.17 | - | - |
| Cash And Equivalents | $32.3M | - | - |
| Total Assets | $178.3M | - | - |
| Total Liabilities | $27.0M | - | - |
| Shareholders Equity | $151.3M | - | - |
| Operating Cash Flow | $-18.6M | - | - |
| Capital Expenditures | $50,000 | - | - |